<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p28" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_28{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_28{left:341px;bottom:30px;}
#t3_28{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_28{left:377px;bottom:30px;}
#t5_28{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_28{left:540px;bottom:30px;}
#t7_28{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_28{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_28{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_28{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_28{left:285px;bottom:827px;letter-spacing:-0.26px;}
#tc_28{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_28{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_28{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_28{left:1109px;bottom:28px;letter-spacing:0.29px;}
#tg_28{left:36px;bottom:192px;}
#th_28{left:46px;bottom:186px;letter-spacing:0.13px;}
#ti_28{left:247px;bottom:186px;}
#tj_28{left:36px;bottom:177px;}
#tk_28{left:46px;bottom:171px;letter-spacing:0.13px;word-spacing:-0.06px;}
#tl_28{left:331px;bottom:171px;}
#tm_28{left:36px;bottom:162px;}
#tn_28{left:42px;bottom:156px;letter-spacing:0.13px;}
#to_28{left:257px;bottom:156px;}
#tp_28{left:36px;bottom:146px;}
#tq_28{left:42px;bottom:140px;letter-spacing:0.12px;}
#tr_28{left:45px;bottom:125px;letter-spacing:0.11px;word-spacing:0.02px;}
#ts_28{left:45px;bottom:110px;letter-spacing:0.12px;}
#tt_28{left:329px;bottom:110px;letter-spacing:0.13px;}
#tu_28{left:413px;bottom:110px;}
#tv_28{left:36px;bottom:778px;letter-spacing:0.48px;}
#tw_28{left:36px;bottom:760px;letter-spacing:0.25px;}
#tx_28{left:208px;bottom:778px;letter-spacing:0.32px;word-spacing:-0.31px;}
#ty_28{left:797px;bottom:778px;letter-spacing:0.28px;word-spacing:-0.12px;}
#tz_28{left:36px;bottom:552px;letter-spacing:-0.1px;}
#t10_28{left:36px;bottom:534px;letter-spacing:-0.08px;}
#t11_28{left:36px;bottom:515px;letter-spacing:-0.09px;}
#t12_28{left:36px;bottom:497px;letter-spacing:-0.1px;}
#t13_28{left:36px;bottom:479px;letter-spacing:-0.08px;}
#t14_28{left:36px;bottom:460px;letter-spacing:-0.07px;}
#t15_28{left:36px;bottom:442px;letter-spacing:-0.09px;}
#t16_28{left:36px;bottom:424px;letter-spacing:-0.11px;}
#t17_28{left:208px;bottom:723px;letter-spacing:-0.1px;}
#t18_28{left:403px;bottom:730px;letter-spacing:-0.09px;}
#t19_28{left:208px;bottom:687px;letter-spacing:-0.1px;}
#t1a_28{left:208px;bottom:644px;letter-spacing:-0.08px;}
#t1b_28{left:208px;bottom:626px;letter-spacing:-0.1px;}
#t1c_28{left:208px;bottom:608px;letter-spacing:-0.08px;}
#t1d_28{left:208px;bottom:589px;letter-spacing:-0.09px;}
#t1e_28{left:208px;bottom:571px;letter-spacing:-0.09px;}
#t1f_28{left:208px;bottom:553px;letter-spacing:-0.09px;}
#t1g_28{left:208px;bottom:534px;letter-spacing:-0.08px;}
#t1h_28{left:208px;bottom:516px;letter-spacing:-0.1px;}
#t1i_28{left:390px;bottom:524px;}
#t1j_28{left:208px;bottom:429px;letter-spacing:-0.1px;}
#t1k_28{left:208px;bottom:366px;letter-spacing:-0.1px;}
#t1l_28{left:208px;bottom:348px;letter-spacing:-0.1px;}
#t1m_28{left:297px;bottom:356px;letter-spacing:-0.13px;}
#t1n_28{left:208px;bottom:290px;letter-spacing:-0.1px;}
#t1o_28{left:208px;bottom:236px;letter-spacing:-0.08px;}
#t1p_28{left:1066px;bottom:591px;letter-spacing:-0.1px;}
#t1q_28{left:1066px;bottom:573px;letter-spacing:-0.09px;}
#t1r_28{left:1066px;bottom:554px;letter-spacing:-0.08px;}
#t1s_28{left:1074px;bottom:489px;letter-spacing:-0.09px;}
#t1t_28{left:1074px;bottom:471px;letter-spacing:-0.06px;}
#t1u_28{left:1074px;bottom:452px;letter-spacing:-0.08px;}
#t1v_28{left:1074px;bottom:434px;letter-spacing:-0.09px;}
#t1w_28{left:1074px;bottom:416px;letter-spacing:-0.25px;}
#t1x_28{left:799px;bottom:732px;letter-spacing:-0.1px;}
#t1y_28{left:799px;bottom:714px;letter-spacing:-0.1px;}
#t1z_28{left:918px;bottom:714px;letter-spacing:-0.11px;}
#t20_28{left:458px;bottom:669px;letter-spacing:-0.1px;}
#t21_28{left:777px;bottom:676px;}
#t22_28{left:458px;bottom:473px;letter-spacing:-0.1px;}
#t23_28{left:458px;bottom:455px;letter-spacing:-0.09px;}
#t24_28{left:458px;bottom:437px;letter-spacing:-0.09px;}
#t25_28{left:523px;bottom:444px;}
#t26_28{left:589px;bottom:524px;letter-spacing:-0.09px;}
#t27_28{left:589px;bottom:506px;letter-spacing:-0.09px;}
#t28_28{left:589px;bottom:488px;letter-spacing:-0.1px;}
#t29_28{left:589px;bottom:426px;letter-spacing:-0.08px;}
#t2a_28{left:589px;bottom:407px;letter-spacing:-0.09px;}
#t2b_28{left:797px;bottom:516px;letter-spacing:-0.1px;}
#t2c_28{left:965px;bottom:524px;letter-spacing:-0.09px;}
#t2d_28{left:797px;bottom:498px;letter-spacing:-0.09px;}
#t2e_28{left:797px;bottom:454px;letter-spacing:-0.13px;}
#t2f_28{left:821px;bottom:461px;}
#t2g_28{left:797px;bottom:435px;letter-spacing:-0.06px;}
#t2h_28{left:797px;bottom:417px;letter-spacing:-0.26px;}
#t2i_28{left:797px;bottom:399px;letter-spacing:-0.1px;}
#t2j_28{left:886px;bottom:406px;letter-spacing:-0.12px;}
#t2k_28{left:459px;bottom:741px;letter-spacing:-0.09px;}
#t2l_28{left:459px;bottom:723px;letter-spacing:-0.09px;}
#t2m_28{left:459px;bottom:705px;letter-spacing:-0.1px;}
#t2n_28{left:619px;bottom:712px;}
#t2o_28{left:575px;bottom:178px;}
#t2p_28{left:584px;bottom:172px;letter-spacing:0.12px;word-spacing:-0.03px;}
#t2q_28{left:1094px;bottom:172px;}
#t2r_28{left:575px;bottom:163px;}
#t2s_28{left:581px;bottom:157px;letter-spacing:0.12px;}
#t2t_28{left:583px;bottom:142px;letter-spacing:0.12px;}
#t2u_28{left:575px;bottom:133px;}
#t2v_28{left:588px;bottom:127px;letter-spacing:0.1px;word-spacing:0.03px;}
#t2w_28{left:583px;bottom:111px;letter-spacing:0.08px;}
#t2x_28{left:605px;bottom:111px;letter-spacing:0.12px;word-spacing:-0.02px;}
#t2y_28{left:1147px;bottom:111px;}
#t2z_28{left:797px;bottom:349px;letter-spacing:-0.09px;}
#t30_28{left:1054px;bottom:349px;letter-spacing:-0.25px;}
#t31_28{left:458px;bottom:363px;letter-spacing:-0.1px;}
#t32_28{left:458px;bottom:343px;letter-spacing:-0.09px;}
#t33_28{left:458px;bottom:596px;letter-spacing:-0.09px;}
#t34_28{left:458px;bottom:577px;letter-spacing:-0.09px;}
#t35_28{left:613px;bottom:585px;}
#t36_28{left:797px;bottom:585px;letter-spacing:-0.11px;}
#t37_28{left:897px;bottom:592px;}
#t38_28{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_28{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_28{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_28{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_28{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_28{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_28{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_28{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_28{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_28{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_28{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sa_28{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sb_28{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sc_28{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sd_28{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts28" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

</style>
<div id="pg28Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg28" style="-webkit-user-select: none;"><object width="1210" height="935" data="28/28.svg" type="image/svg+xml" id="pdf28" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_28" class="t s0_28">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_28" class="t s1_28">® </span>
<span id="t3_28" class="t s0_28">(NCCN </span>
<span id="t4_28" class="t s1_28">® </span>
<span id="t5_28" class="t s0_28">), All rights reserved. NCCN Guidelines </span>
<span id="t6_28" class="t s1_28">® </span>
<span id="t7_28" class="t s0_28">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_28" class="t s2_28">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_28" class="t s2_28">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_28" class="t s3_28">NCCN Guidelines Version 4.2024 </span>
<span id="tb_28" class="t s3_28">Cancer of the Hypopharynx </span>
<span id="tc_28" class="t s4_28">NCCN Guidelines Index </span>
<span id="td_28" class="t s4_28">Table of Contents </span>
<span id="te_28" class="t s4_28">Discussion </span>
<span id="tf_28" class="t s5_28">HYPO-3 </span>
<span id="tg_28" class="t s6_28">d </span>
<span id="th_28" class="t s7_28">Principles of Imaging (IMG-A)</span><span id="ti_28" class="t s8_28">. </span>
<span id="tj_28" class="t s6_28">h </span>
<span id="tk_28" class="t s7_28">Principles of Radiation Therapy (HYPO-A)</span><span id="tl_28" class="t s8_28">. </span>
<span id="tm_28" class="t s6_28">i </span>
<span id="tn_28" class="t s7_28">Principles of Surgery (SURG-A)</span><span id="to_28" class="t s8_28">. </span>
<span id="tp_28" class="t s6_28">j </span>
<span id="tq_28" class="t s8_28">Adverse pathologic features: extranodal extension, positive margins, close </span>
<span id="tr_28" class="t s8_28">margins, pT3 or pT4 primary, pN2 or pN3 nodal disease, perineural invasion, </span>
<span id="ts_28" class="t s8_28">vascular invasion, and lymphatic invasion </span><span id="tt_28" class="t s7_28">(Discussion)</span><span id="tu_28" class="t s8_28">. </span>
<span id="tv_28" class="t s5_28">CLINICAL </span>
<span id="tw_28" class="t s5_28">STAGING </span>
<span id="tx_28" class="t s5_28">TREATMENT OF PRIMARY AND NECK </span><span id="ty_28" class="t s5_28">ADJUVANT TREATMENT </span>
<span id="tz_28" class="t s5_28">T2–3,N0–3 </span>
<span id="t10_28" class="t s9_28">(if requiring </span>
<span id="t11_28" class="t s5_28">[amenable to] </span>
<span id="t12_28" class="t s5_28">pharyngectomy </span>
<span id="t13_28" class="t s5_28">with partial </span>
<span id="t14_28" class="t s5_28">or total </span>
<span id="t15_28" class="t s5_28">laryngectomy); </span>
<span id="t16_28" class="t s5_28">T1,N+ </span>
<span id="t17_28" class="t s5_28">Induction chemotherapy </span>
<span id="t18_28" class="t sa_28">k,l </span>
<span id="t19_28" class="t s5_28">or </span>
<span id="t1a_28" class="t s5_28">Partial or total </span>
<span id="t1b_28" class="t s5_28">laryngopharyngectomy </span>
<span id="t1c_28" class="t s5_28">+ ipsilateral or bilateral </span>
<span id="t1d_28" class="t s5_28">neck dissection ± hemi- </span>
<span id="t1e_28" class="t s5_28">or total thyroidectomy </span>
<span id="t1f_28" class="t s5_28">and pretracheal and </span>
<span id="t1g_28" class="t s5_28">ipsilateral paratracheal </span>
<span id="t1h_28" class="t s5_28">lymph node dissection </span>
<span id="t1i_28" class="t sa_28">i </span>
<span id="t1j_28" class="t s5_28">or </span>
<span id="t1k_28" class="t s5_28">Concurrent systemic </span>
<span id="t1l_28" class="t s5_28">therapy/RT </span>
<span id="t1m_28" class="t sa_28">h,k,m </span>
<span id="t1n_28" class="t s5_28">or </span>
<span id="t1o_28" class="t s5_28">Clinical trials </span>
<span id="t1p_28" class="t s5_28">Follow-up </span>
<span id="t1q_28" class="t sb_28">(FOLL-A, 1 </span>
<span id="t1r_28" class="t sb_28">of 2) </span>
<span id="t1s_28" class="t s5_28">Recurrent </span>
<span id="t1t_28" class="t s5_28">or </span>
<span id="t1u_28" class="t s5_28">persistent </span>
<span id="t1v_28" class="t s5_28">disease </span>
<span id="t1w_28" class="t sb_28">(ADV-3) </span>
<span id="t1x_28" class="t s5_28">Response after induction </span>
<span id="t1y_28" class="t s5_28">chemotherapy </span><span id="t1z_28" class="t sb_28">(HYPO-4) </span>
<span id="t20_28" class="t s5_28">pN0 and no adverse pathologic features </span>
<span id="t21_28" class="t sa_28">j </span>
<span id="t22_28" class="t s5_28">Adverse </span>
<span id="t23_28" class="t s5_28">pathologic </span>
<span id="t24_28" class="t s5_28">features </span>
<span id="t25_28" class="t sa_28">j </span>
<span id="t26_28" class="t s5_28">Extranodal </span>
<span id="t27_28" class="t s5_28">extension and/or </span>
<span id="t28_28" class="t s5_28">positive margin </span>
<span id="t29_28" class="t s5_28">Other risk </span>
<span id="t2a_28" class="t s5_28">features </span>
<span id="t2b_28" class="t s5_28">Systemic therapy/RT </span>
<span id="t2c_28" class="t sa_28">h,k </span>
<span id="t2d_28" class="t s5_28">(category 1) </span>
<span id="t2e_28" class="t s5_28">RT </span>
<span id="t2f_28" class="t sa_28">h </span>
<span id="t2g_28" class="t s5_28">or </span>
<span id="t2h_28" class="t s5_28">Consider systemic </span>
<span id="t2i_28" class="t s5_28">therapy/RT </span>
<span id="t2j_28" class="t sa_28">h,k </span>
<span id="t2k_28" class="t s5_28">CT (with contrast) or MRI </span>
<span id="t2l_28" class="t s5_28">(with and without contrast) </span>
<span id="t2m_28" class="t s5_28">of primary and neck </span>
<span id="t2n_28" class="t sa_28">d </span>
<span id="t2o_28" class="t s6_28">k </span>
<span id="t2p_28" class="t s7_28">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="t2q_28" class="t s8_28">. </span>
<span id="t2r_28" class="t s6_28">l </span>
<span id="t2s_28" class="t sc_28">In randomized clinical trials, assessment of response has been done after 2 or 3 </span>
<span id="t2t_28" class="t s8_28">cycles. </span>
<span id="t2u_28" class="t s6_28">m </span>
<span id="t2v_28" class="t s8_28">When using concurrent systemic therapy/RT, the preferred agent is cisplatin (category </span>
<span id="t2w_28" class="t s8_28">1). </span><span id="t2x_28" class="t s7_28">See Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="t2y_28" class="t s8_28">. </span>
<span id="t2z_28" class="t s5_28">Recurrent or persistent disease </span><span id="t30_28" class="t sb_28">(ADV-3) </span>
<span id="t31_28" class="t sb_28">Post Systemic Therapy/RT or RT </span>
<span id="t32_28" class="t sb_28">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t33_28" class="t s5_28">pN1 without other adverse </span>
<span id="t34_28" class="t s5_28">pathologic features </span>
<span id="t35_28" class="t sa_28">j </span><span id="t36_28" class="t s5_28">Consider RT </span>
<span id="t37_28" class="t sa_28">h </span>
<span id="t38_28" class="t sd_28">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
